Vaxcyte Inc
General ticker "PCVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $11.2B
Vaxcyte Inc follows the US Stock Market performance with the rate: 41.5%.
Estimated limits based on current volatility of 1.9%: low 85.34$, high 88.89$
Factors to consider:
- Current price 24.8% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [34.95$, 69.77$]
- 2024-12-30 to 2025-12-30 estimated range: [24.73$, 52.64$]
Financial Metrics affecting the PCVX estimates:
- Negative: Non-GAAP EPS, $ of -4.13 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -5.10 <= 2.35
- Negative: negative Net income
- Negative: Investing cash flow per share, $ of -7.96 <= -3.48
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term PCVX quotes
Long-term PCVX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $103.67MM | $232.26MM | $468.04MM |
| Operating Income | $-103.67MM | $-232.26MM | $-468.04MM |
| Non-Operating Income | $3.59MM | $8.77MM | $65.78MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $78.41MM | $169.45MM | $332.34MM |
| Income(Loss) | $-100.08MM | $-223.49MM | $-402.27MM |
| Profit(Loss) | $-100.08MM | $-223.49MM | $-402.27MM |
| Stockholders Equity | $284.02MM | $953.61MM | $1,240.47MM |
| Inventory | $1.20MM | $1.00MM | $0.00MM |
| Assets | $324.34MM | $1,006.18MM | $1,407.92MM |
| Operating Cash Flow | $-121.39MM | $-170.60MM | $-296.79MM |
| Capital expenditure | $6.55MM | $5.85MM | $67.88MM |
| Investing Cash Flow | $-212.31MM | $74.58MM | $-773.31MM |
| Financing Cash Flow | $17.80MM | $861.55MM | $639.81MM |
| Earnings Per Share* | $-1.93 | $-3.69 | $-4.14 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.